Credit: Medtronic

The first so-called artificial pancreas systems – wearable devices that take charge of the crucial process of measuring glucose and delivering insulin –  are now beginning to come to market.

That’s welcome news for the nation’s 30 million diabetics, who stand not only to get some relief from the seemingly incessant stream of lancets, test strips and syringes, but also to stay healthier. That’s because an artificial pancreas can keep the disease on a tighter leash than they can, by testing more frequently and delivering more precise insulin doses.

That’s not only important for patients, but could ease strains on the nation’s healthcare system.

Read my entire column in the Tech section of USA Today HERE.